Inactive Instrument

Highlights DEINOVE OTC Markets

Equities

DNVVF

FR0010879056

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

Court Reserves Decision On Deinove Receivership Proceedings	17/01/23	MT
Deinove SA Reports Earnings Results for the Half Year Ended June 30, 2022	06/10/22	CI
Deinove SA Reports Earnings Results for the Full Year Ended December 31, 2021	08/04/22	CI
Deinove SA Announces the Extension of Its Clinical Trial to Canada	07/04/22	CI
Deinove SA Announces A Favorable Opinion from the DSMBfor the Continuation of the Phase II Clinical Trial of DNV3837 in Clostridioides Difficile Infections	06/01/22	CI
Deinove Announces Collaboration with Max Mousseron Institute of Biomolecules and the LMP of the University of Montpellier	30/06/21	CI
Deinove SA Announces Consolidated Financial Results for the Year Ended December 31, 2020	25/03/21	CI
Deinove SA Signs an Evaluation and Technology Development License with DSM	19/11/20	CI
Deinove Sa Reports Earnings Results for the Half Year Ended June 30, 2020	30/09/20	CI
DEINOVE Pursues Phase II Clinical Trial of its Antibiotic Candidate DNV3837	15/07/20	CI
Deinove Sa Reports Earnings Results for the Full Year Ended December 31, 2019	29/04/20	CI
DEINOVE Announces the Official Launch of Luminity	23/04/20	CI
DEINOVE Provides Update on BIOME Oléoactif	18/03/20	CI
Deinove SA Expands its Range of Cosmetic Active Ingredients	19/02/20	CI
Sharon Laboratories Capitalizes on Deinove to Sustain Its Development Activities	06/02/20	CI
DEINOVE Announces the Inclusion of the First Patient in the Phase II Trial Testing DNV3837	27/01/20	CI
DEINOVE Announces the Production of New Industrial Batch of Phyt-N-Resist	22/01/20	CI
Deinove Announces Consolidated Earnings Results for the Six Months Ended June 30, 2019	26/09/19	CI
Deinove Announces Integration of CRISPR-case9 Technology to Accelerate the Discovery of Innovative Antibiotics	23/09/19	CI
DEINOVE Announces DNV3681's Exceptional Activity Against Bioterrorist Threats Presented at ASM Microbe 2019	24/06/19	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights DEINOVE OTC Markets

Equities

DNVVF

FR0010879056

Highlights

Filters